Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04366089
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:43.520545+00:00
Published At
2020-04-28T00:00:00+00:00
Record Updated At
2020-04-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["COVID", "SARS-CoV 2", "Pneumonia, Viral", "Coronavirus Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-04-28"
protocolSection.identificationModule.nctId
"NCT04366089"
protocolSection.identificationModule.officialTitle
"Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • COVID (protocolSection.conditionsModule.conditions)
  • SARS-CoV 2 (protocolSection.conditionsModule.conditions)
  • Pneumonia, Viral (protocolSection.conditionsModule.conditions)
  • Coronavirus Infection (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.